Evaluation of Quality of Life in Women

• Sponsor: Hacettepe University (Other)
• Overall Status: Completed
• CT.gov ID: NCT04164628
• Collaborator: (none)
• Enrollment: 227
• Location: 1
• Arm: 1
• Actual Duration (Months): 6.9
• Patients Per Site Per Month: 32.7

Study Details

Study Description

Brief Summary

300 women will be evaluated in this study. Their quality of life, level of physical activity, Social Functioning, levels of depression and musculoskeletal status will be assessed.

Condition or Disease	Intervention/Treatment	Phase
Quality of Life; Women Health; Social Interaction	Other: Quality of life assessment	N/A

Detailed Description

Many factors affects quality of life in women. In the literature, factors affecting the quality of life such as diseases, working conditions and psychological factors of women have been investigated in different diseases. However, there was no study investigating the factors affecting quality of life for a sample of adult female individuals. Therefore, the aim of our study is to investigate the effect of social, psychological and physical variables that we think may affect the quality of life in women.

Study Design

• Study Type: Interventional
• Actual Enrollment: 227 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: Investigation of Affecting Factors Quality of Life in Women
• Actual Study Start Date: Nov 30, 2019
• Actual Primary Completion Date: Jun 1, 2020
• Actual Study Completion Date: Jun 28, 2020

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Experimental Group: quality of life assessment Women's quality of life will be evaluated.	Other: Quality of life assessment; Quality of life will be assessed with Nottingham Health Profile

Outcome Measures

Primary Outcome Measures

1. Quality of life [5 minutes]

   The Nottingham Health Profile is a general patient self-evaluation of subjective health status. The score of this questionnaire ranges between 0 and 600. The higher score indicates the worse quality of life.

Secondary Outcome Measures

1. Social Functioning Scale [10 minutes]

   Questionnaire is specifically designed to assess the most relevant areas of social functioning. The higher score indicates the better social function.

2. Depression scale [5 minutes]

   The Beck Depression Inventory is a 21-item self-administered scale measuring various symptoms of depression. It comprises 21 groups of statements describing the somatic and cognitive-emotional symptoms of depression. Each item consists of four alternative responses. graded from 0 to 3 according to the severity of the symptom. The patients choose the response closest to their state during the past week. A sum score is counted, a higher score indicating more severe depression

3. physical activity level [5 minutes]

   Physical activity was assessed using the self-administered short (7-item) forms of the international physical activity questionnaire. The higher score indicates the more physically active lifestyle.

4. Musculoskeletal status [5 minutes]

   The Nordic musculoskeletal questionnaire includes 27 items exploring the presence of musculoskeletal symptoms during a 12-month period covering the nine different parts of the body. The higher score indicates the worse musculoskeletal status.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 60 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• To be a volunteer

Exclusion Criteria:

• having severe musculoskeletal system disorders

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hacettepe University	Ankara		Turkey	06100

Sponsors and Collaborators

• Hacettepe University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Arzu Demircioğlu, PT, Research Assisstant, MSc, Hacettepe University
• ClinicalTrials.gov Identifier: NCT04164628
• Other Study ID Numbers: GO 19/1046
• First Posted: Nov 15, 2019
• Last Update Posted: Jun 30, 2020
• Last Verified: Jun 1, 2020

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Arzu Demircioğlu, PT, Research Assisstant, MSc, Hacettepe University: quality of life; depression; anxiety; social function

Study Results

No Results Posted as of Jun 30, 2020